recent advances in the treatment and management of itp
Published 1 year ago • 253 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
1:55
latest updates in the management of immune thrombocytopenia
-
1:29
novel promising agents for the treatment of itp
-
1:32
shifting the treatment landscape of itp: novel agents and future outlooks
-
4:18
recent advances in the clinical management of myeloma
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
1:06:04
itp: novel treatments
-
10:03
exploring natural remedies for itp: 5 alternatives to prednisone
-
28:08
dr. gaby hobbs, md: diagnosis and initial treatment options for et, pv & mf
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
2:38
the management of itp during and after the covid-19 pandemic
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
2:25
key ebmt guideline updates for the treatment and prophylaxis of gvhd
-
1:07
key advancements in the treatment of bpdcn from ebmt 2024
-
1:19
the potential of caplacizumab in the treatment of attp
-
4:14
long-term safety and efficacy of sutimlimab for chronic itp
-
3:11
the therapeutic implications of shared pathophysiology in classical itp and other thrombocytopenias
-
1:09
emerging treatment options for refractory immune thrombocytopenia
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
2:41
advances in the treatment and prognosis of ttp
-
2:43
the management of advanced phase mpns
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
0:51
key unmet needs in the treatment of immune-mediated ttp